Vitiligo and the Koebner Phenomenon (Model of Vitiligo Induction and Therapy: a Clinical and Immunological Analysis)

• Status: Unknown status
• Trial end date: 2015-12-01
• Target enrollment: 0
• Participant gender: All

Summary

We will investigate the process of vitiligo induction and the influence of different commonly used cream treatments on this process. Studies comparing different treatments for vitiligo in the induction stage of the disease are still missing. The study hypothesis = cream treatment can stop actively spreading vitiligo lesions during the early induction stage of the disease.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University Hospital, Ghent
• Treatments: Mometasone Furoate; Pimecrolimus; Tacrolimus

Criteria

Inclusion Criteria:

• Male and female,

• Age 18-70 years,

• Extensive vitiligo (> 50% body surface area),

• Patients asking for depigmenting therapy,

• Not pregnant.

Exclusion Criteria:

• Children,

• Non extensive vitiligo (< 50% boy surface area),

• Patients not asking for depigmenting therapies,

• Pregnant.